Literature DB >> 19461414

Genetic thrombophilias and intrauterine growth restriction: a meta-analysis.

Francesca Facco1, Whitney You, William Grobman.   

Abstract

OBJECTIVE: To estimate the relationship between inherited thrombophilias and intrauterine growth restriction (IUGR) using meta-analytic techniques.
METHODS: A literature review identified case-control and cohort studies evaluating the relationship between IUGR and the following thrombophilias: homozygous or heterozygous factor V Leiden or prothrombin (PT) G20210A mutations and homozygous methylenetetrahydrofolate reductase (MTHFR) C677T mutation. Using mixed effects and random-effects models, the association between thrombophilias and IUGR was explored. Publication bias was assessed with funnel plots and corrected for with Duval and Tweedie's trim-and-fill method.
RESULTS: The following number of related studies were found: studies evaluating relationships between factor V Leiden mutation and IUGR, 12 case-control and four cohort; between PT mutation and IUGR, 11 case-control and 0 cohort; and between MTHFR C677T homozygosity and IUGR, 10 case-control and two cohort. The overall summary odds ratio (OR) for the association between factor V Leiden and IUGR was significant (OR 1.23, 95% confidence interval [CI] 1.04-1.44); however, this was mainly driven by the positive association seen in the case-control studies (OR 1.91, 95% CI 1.17-3.12). The association between PT and IUGR was only explored in case-control studies yielding a summary OR that was not significant (OR 1.52, 95% CI 0.98-2.35). The overall summary OR for the association between MTHFR and IUGR was not significant (OR 1.01, 95% CI 0.88-1.17), but was significant for the case-control studies alone (OR 1.35, 95% CI 1.04-1.75). For both factor V Leiden and MTHFR mutations, a funnel-plot analysis of the case-control studies suggests publication bias. When the trim-and fill-method was used to correct for the publication bias, these summary estimates were no longer significant.
CONCLUSION: The association between inherited thrombophilias and IUGR can only be discerned in case-control studies and seems to be largely because of publication bias. LEVEL OF EVIDENCE: III.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19461414     DOI: 10.1097/AOG.0b013e3181a6e96a

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  11 in total

1.  Inherited thrombophilia in pregnant women with intrauterine growth restriction.

Authors:  Letitia Coriu; Elena Copaciu; Dan Tulbure; Rodica Talmaci; Diana Secara; Daniel Coriu; Monica Cirstoiu
Journal:  Maedica (Buchar)       Date:  2014-12

2.  Ethnic differences in the association of thrombophilic polymorphisms with obstetric complications in Slovak and Roma (Gypsy) populations.

Authors:  Alexandra Bozikova; Dana Gabrikova; Jozef Pitonak; Jarmila Bernasovska; Sona Macekova; Regina Lohajova-Behulova
Journal:  Genet Test Mol Biomarkers       Date:  2014-12-30

3.  Elevated lipoprotein(a) levels and homozygous human platelet antigen 1b (HPA-1b) genotype are risk factors for intrauterine growth restriction (IUGR).

Authors:  Andrea Gerhardt; Nadja Howe; Jan Steffen Krüssel; Ruediger Eberhard Scharf; Rainer Bernd Zotz
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300

Review 4.  The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies.

Authors:  Marc A Rodger; Marisol T Betancourt; Peter Clark; Pelle G Lindqvist; Donna Dizon-Townson; Joanne Said; Uri Seligsohn; Marc Carrier; Ophira Salomon; Ian A Greer
Journal:  PLoS Med       Date:  2010-06-15       Impact factor: 11.069

5.  Prothrombin gene G20210A mutation and obstetric complications.

Authors:  Robert M Silver; Yuan Zhao; Catherine Y Spong; Baha Sibai; George Wendel; Katharine Wenstrom; Philip Samuels; Steve N Caritis; Yoram Sorokin; Menachem Miodovnik; Mary J O'Sullivan; Deborah Conway; Ronald J Wapner
Journal:  Obstet Gynecol       Date:  2010-01       Impact factor: 7.623

6.  The Impact of Inherited Thrombophilia Types and Low Molecular Weight Heparin Treatment on Pregnancy Complications in Women with Previous Adverse Outcome.

Authors:  Nada Aracic; Damir Roje; Ivana Alujevic Jakus; Marinela Bakotin; Vedran Stefanovic
Journal:  Yonsei Med J       Date:  2016-09       Impact factor: 2.759

7.  The association between IUGR and maternal inherited thrombophilias: A case-control study.

Authors:  Stefan Dugalić; Milos Petronijevic; Aleksandar Stefanovic; Katarina Jeremic; Svetlana Vrzic Petronijevic; Ivan Soldatovic; Igor Pantic; Irena Djunic; Zoran Jokic; Filip Djokovic; Jelena Dotlic; Milica Zaric; Jovana Todorovic
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

Review 8.  The obstetric complications in women with hereditary thrombophilia.

Authors:  Diana Mitriuc; Olga Popuşoi; Rodica Catrinici; Valentin Friptu
Journal:  Med Pharm Rep       Date:  2019-04-25

9.  Evaluation of placental vascularization in thrombophilia and intrauterine growth restriction (IUGR).

Authors:  Nicoleta Loredana Voicu; Roxana Elena Bohîlţea; Sabina Berceanu; Cristina Jana Busuioc; Gabriela Camelia Roşu; Ştefan Paitici; Anca Maria Istrate-Ofiţeru; Costin Berceanu; Damian Diţescu
Journal:  Rom J Morphol Embryol       Date:  2020 Apr-Jun       Impact factor: 1.033

10.  Individual risk assessment of adverse pregnancy outcome by multivariate regression analysis may serve as basis for drug intervention studies: retrospective analysis of 426 high-risk patients including ethical aspects.

Authors:  Rolf Becker; Thomas Keller; Holger Kiesewetter; Heiner Fangerau; Uta Bittner
Journal:  Arch Gynecol Obstet       Date:  2013-02-07       Impact factor: 2.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.